ARCHIVES

NCI Develops Plan For Specialized Centers, But Funding $67.5M Program Depends On New $$

This article is from The Cancer Letter archive.

Vol. 17 No. 27 | July 5, 1991

Download PDF Visit The Full Archive

Related Articles

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

August 31, 2012

Former BMS Executive Bodnar Indicted.

April 25, 2008

In Brief: PCORI Forms Clinical Trials Advisory Board

April 4, 2014

Nexavar Improves PFS In Phase III Trial

January 25, 2013

Finasteride Raises Odds Of Finding Fast-Growing Cancers Early, Study Says

September 28, 2007

Moertel Criticizes Janssen Over Levamisole Price, Delivers Final Report On Intergroup Adjuvant Trial

June 12, 1992